Understanding Weighing The Evidence Direct Oral Anticoagulant Use In Obese Patients
If you are looking for information about Weighing The Evidence Direct Oral Anticoagulant Use In Obese Patients, you have come to the right place. This is a recording of a live continuing education program provided by one of our PGY2 Cardiology Pharmacy Residents, Dr.
Key Takeaways about Weighing The Evidence Direct Oral Anticoagulant Use In Obese Patients
- With their ease of
- HPS and its network of approved pharmacies are pleased to present this webcast (#4) recording on the topic, 'Treating
- Laura Talamo, MD discusses the results of retrospective analysis of a random sample of
- Date: September 15, 2021 Presenters: Arthur Allen, PharmD, CACP, Karlyn Martin, MD, Stephan Moll, MD, Deborah Siegal, MD, ...
- Date: May 25, 2021 Presenters: Arthur Allen, PharmD, CACP, Geoffrey Barnes, MD, MSc, Adam Cuker, MD, MS, Ghadeer ...
Detailed Analysis of Weighing The Evidence Direct Oral Anticoagulant Use In Obese Patients
This activity addressed the complexity of managing Chaired by: Dr Catherine Bagot Speaker: Victoria Speed. ... us for today's educational activity titled
Session in collaboration with UK Clinical Pharmacy Association (UKCPA) Chaired by Stephane Jaglin. Presentations by Rosalind ...
We hope this detailed breakdown of Weighing The Evidence Direct Oral Anticoagulant Use In Obese Patients was helpful.